Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine

AIDS

Volumn 16, Issue 4, 2002, Pages 625-630

  Ekpini, René Anatole ^a   Nkengasong, John N ^a   Sibailly, Toussaint ^a   Maurice, Chantal ^a   Adjé, Christiane ^a   Monga, Ben B ^a   Roels, Thierry H ^a   Greenberg, Alan E ^a   Wiktor, Stefan Z ^a  

^a Project RETRO CI Abidjan   (Côte d’Ivoire)

Author keywords

C te d'Ivoire; HIV 1; Mother to child transmission; Viral load; Zidovudine

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PLACEBO; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA SEQUENCE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERTICAL TRANSMISSION; VIRUS INFECTION; VIRUS LOAD;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COTE D'IVOIRE; DRUG RESISTANCE, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD; ZIDOVUDINE;

EID: 0037040374     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200203080-00015     Document Type: Article

References (20)

1. Short-course zidovudine for prevention of mother-to-child transmission of HIV-1 in Bangkok, Thailand: A randomised trial
2. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'lvoire: A randomised trial
3. 6-Month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: A double-blind placebo-controlled multicentre trial
4. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
5. The PETRA study: Early and late efficacy of three short ZDV/3TC combination regimens to prevent mother-to-child transmission of HIV-1
6. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
7. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
8. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand
9. Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial
10. Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment
11. High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy
12. Rebound of HIV-1 viral load after suppression to very Iow levels
13. Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission
14. Rapid and specific diagnosis of HIV-1 and HIV-1 infections: An evaluation of testing strategies
15. Evaluation of HIV serologic parallel and serial testing algorithms in Abidjan, Côte d'Ivoire
16. Field evaluation of a combination of monospecific ELISAs for the type-specific serodiagnosis of HIV-1 and HIV-2 infections in seropositive persons in Abidjan, Côte d'Ivoire
17. Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial
18. Immunosuppression in pregnant women infected with human immunodeficiency virus
19. Two distinct patterns of HIV-1 viral load in early breast milk of HIV+ women treated with short-course zidovudine (ZDV) in Abidian, Cote d'Ivoire
20. Maternal viral zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in Pediatric AIDS Clinical Trials Group Protocol 076